ECT Therapy: How It Works, Who It Helps, and Modern Safety

Your psychiatrist says three letters out loud, ECT, and the room goes quiet. Maybe you’ve tried three antidepressants. Maybe you’ve stopped eating, or the thoughts about not being here have gotten louder. And the picture in your head comes from an old movie. If that’s where you are, the fear makes sense, and you deserve current facts before you decide anything.

Your brain runs on electrical and chemical signaling between nerve cells, and severe depression changes how some of those networks behave. ECT uses a brief, measured electrical current, given while you’re under general anesthesia, to trigger a short, controlled seizure. Researchers are still working out exactly why that helps, but they know the details matter: electrode placement and electrical dose affect how well it works, and placement and pulse length affect how much it touches memory. That’s why modern ECT is a procedure built on precision.

The standard form of ECT has a deep evidence base. A Lancet meta-analysis by the UK ECT Review Group found that real ECT beat simulated ECT and beat medication in short-term trials, and that bilateral ECT, with electrodes on both sides of the head, was moderately more effective than one-sided placement. In a multicenter CORE study of 253 people with severe depression treated with bilateral ECT, 87% of those who completed the course reached remission. The effect is real, and it’s well established.

But the ECT most people picture isn’t the ECT given today, and at Siggy we’d rather walk you through the current evidence, memory trade-offs included, than let an old film make the decision for you. Modern ECT pairs anesthesia and a muscle relaxant with settings like right unilateral electrode placement and brief or ultrabrief pulses, which NIMH’s brain stimulation overview says lower the risk of memory loss. This guide covers how ECT works, who it’s for, its memory and safety record, and how it compares with TMS and ketamine. ECT deserves to be judged on what the research shows today, not on how it was portrayed decades ago.

What This Page Covers

• The Short Answer
• What Happens During an ECT Session?
• Who Is a Good Candidate for ECT?
• How Well Does ECT Work?
• Does ECT Cause Memory Loss?
• How Safe Is Modern ECT?
• How Does ECT Compare With TMS, Esketamine, and Ketamine?
• What Happens After a Course of ECT?
• When to Get Help Right Away

The Short Answer

ECT, or electroconvulsive therapy, is a medical procedure for severe depression, bipolar depression, and catatonia. Under general anesthesia, a brief electrical current triggers a controlled seizure that lasts under a minute. A typical course is three sessions a week for several weeks.

It’s one of the most effective and fastest-acting treatments for severe depression. The main trade-off is memory, which usually recovers within weeks, though some people keep gaps around the treatment period. Serious medical complications are rare, and follow-up treatment is needed to prevent relapse.

What Happens During an ECT Session?

Before a first session, you’ll have a psychiatric and medical evaluation. A StatPearls review hosted by the National Library of Medicine notes that a full history and physical exam can reveal risks like heart rhythm problems, heart failure, or conditions inside the skull, and that a team including an anesthesiologist, a psychiatrist, and a nurse gives the treatment.

On treatment day, here’s what NIMH describes:

1. You receive a short-acting general anesthetic and an IV muscle relaxant, so you’re asleep and your body stays still.
2. Electrodes are placed at precise locations on your head.
3. A brief electrical current causes seizure activity in the brain that lasts under a minute. You don’t feel the pulses.
4. You wake up 5 to 10 minutes later, may feel groggy, and are usually alert within about an hour.

Sessions usually happen three times a week, and symptoms typically improve within 6 to 12 treatments. Many people keep taking an antidepressant or mood stabilizer during the course.

Why the seizure helps isn’t fully understood, but brain imaging offers a clue: an MRI review found that ECT was associated with volume increases in brain areas involved in mood and memory, most consistently the hippocampus.

Who Is a Good Candidate for ECT?

Under the FDA’s 2018 order, ECT devices are cleared for catatonia and for severe depressive episodes in people 13 and older with major depression or bipolar disorder, but only when the person is treatment-resistant or needs a rapid response because of severe illness. NIMH describes the two situations:

• Severe depression that hasn’t improved after other treatments like medication and therapy
• A need for a rapid response because of life-threatening circumstances, such as catatonia (being unable to move or respond), suicidal risk, or not eating enough to stay safe

NIMH also notes that ECT can help when medications haven’t worked, can’t be tolerated, or are a poor fit because of physical illness, which is often the case in older adults. It has also been used in some cases for schizophrenia, schizoaffective disorder, and mania.

Two groups stand out in the research. People with psychotic depression, meaning severe depression with delusions or hallucinations, did especially well in the CORE study, where 95% of those who completed treatment reached remission. And for people at acute risk of suicide, another CORE study followed 444 patients. Among the 131 who started with high suicidal intent, their clinician-rated intent dropped to zero in 38.2% after one week, 61.1% after two weeks, and 80.9% by the end of treatment.

ECT isn’t right for everyone. The StatPearls review lists conditions that raise the risk, citing the American Psychiatric Association: unstable or severe heart disease, a brain lesion with raised pressure inside the skull, a history of acute brain bleeding or stroke, an unstable aneurysm, severe lung disease, and very high anesthesia risk. Some of these can rule ECT out, and others call for extra planning with the medical team.

If ECT is on the table, a few questions are worth bringing to the evaluation: which electrode placement and pulse width the team plans to use, how they’ll check your memory during the course, how many sessions they expect, and what the plan is after the last one.

How Well Does ECT Work?

ECT is often called the most effective treatment for severe depression, and the trials above support that. In the CORE study, remission meant low depression scores on two ratings in a row, a strict bar that 87% of people who completed bilateral ECT still met.

Speed is the other difference. NIMH notes that ECT works faster than antidepressant medication, usually taking effect within the first week. That’s why the authors of the CORE suicide study concluded that, for people at risk, ECT should be considered earlier than its usual last-resort position.

One caution: the CORE figures come from research hospitals and count only people who finished the course. A community-based study at seven hospitals found remission rates of 30.3% to 46.7% among 347 patients, depending on the definition, and noted that courses often ended while symptoms remained. It’s fair to ask your team how they’ll measure when you’ve fully responded.

Does ECT Cause Memory Loss?

Memory is the most common worry, so here’s the clear answer: ECT does affect memory, usually temporarily, and technique makes a large difference.

The short-term picture is reassuring. A 2010 meta-analysis of 84 studies and 2,981 patients found that drops in thinking and memory test scores were mostly limited to the first 3 days after ECT. Within about two weeks, scores were back to where they started, and after that, some areas, like processing speed and working memory, tested better than before treatment.

That analysis couldn’t measure memories of past events, because its studies had no standardized test for them. A companion study of the same 347 community hospital patients did, and it found that some people still had gaps in autobiographical memory, their recall of past personal events, 6 months later. Bilateral ECT resulted in more severe and longer-lasting gaps than right unilateral ECT, and older sine-wave devices slowed reaction time. Outcomes varied by hospital, and differences in technique largely explained why.

That’s why NIMH recommends asking about two settings before you start:

• Electrode placement. Right unilateral ECT places one electrode on the right side of the head, opposite the brain’s main learning and memory areas, and the other on top of the head. It carries a lower risk of memory loss than bilateral ECT.
• Pulse width. Brief and ultrabrief pulses are as effective as the traditional form at a lower electrical dose, which further reduces memory side effects.

Choosing right unilateral placement doesn’t have to mean giving up effectiveness. The StatPearls review cites a 2017 meta-analysis of 792 patients in which high-dose right unilateral ECT and moderate-dose bilateral ECT had comparable remission.

Severe depression also affects memory on its own, as our guide to depression and memory loss explains. Keeping a journal or calendar during the course can help fill small gaps.

How Safe Is Modern ECT?

Much of ECT’s reputation comes from its early decades. The StatPearls review notes that the stigma stems largely from early treatments given without anesthesia, which caused significant injuries and severe memory loss. Today, ECT is given with anesthesia, oxygen, and a muscle relaxant, while the team continuously records heart rhythm, oxygen levels, and brain activity.

The safety numbers reflect that change. A pooled analysis of 766,180 treatments across 32 countries estimated 2.1 ECT-related deaths per 100,000 treatments, compared with 3.4 per 100,000 for general anesthesia during surgery. In studies published after 2001, covering 414,747 treatments, there was one reported ECT-related death. And the MRI review, which pooled 32 studies, found no evidence of ECT-related brain damage.

That doesn’t mean ECT is side-effect free. NIMH lists headaches, upset stomach, muscle aches, confusion, and memory loss as the most common side effects. Heart rate and blood pressure rise briefly during the seizure, which is why the medical evaluation beforehand matters.

How Does ECT Compare With TMS, Esketamine, and Ketamine?

ECT is one of several options for treatment-resistant depression. This comparison draws on NIMH, Spravato’s FDA label, and the ELEKT-D trial:

Option	How It’s Given	Typical Course	Common Side Effects
ECT	General anesthesia, brief seizure	3 times a week, often 6 to 12 sessions	Headache, muscle aches, confusion, memory gaps
rTMS	Awake, magnetic coil on the scalp	Daily, 5 days a week for 4 to 6 weeks	Scalp discomfort, mild headache
Esketamine (Spravato)	Nasal spray in a certified clinic, at least 2 hours of monitoring	Twice weekly for 4 weeks, then weekly or every 2 weeks	Dissociation, dizziness, nausea, sedation
IV ketamine (off-label)	Infusion over 40 minutes	Twice weekly for 3 weeks in ELEKT-D	Dissociation

The ELEKT-D trial randomized 403 people with treatment-resistant depression without psychosis to ECT or IV ketamine. After three weeks, 55.4% of the ketamine group and 41.2% of the ECT group had responded, which showed ketamine was noninferior. ECT was associated with a drop in memory recall that gradually recovered, and ketamine with dissociation. The trial was open-label, excluded psychotic depression, and more people assigned to ECT withdrew before starting treatment. Keep in mind that IV ketamine is used off-label: an FDA safety communication states that ketamine isn’t FDA-approved for any psychiatric disorder, while esketamine is.

TMS sits at the gentler end. NIMH notes that it needs no anesthesia and has strong evidence behind it, but it doesn’t match the effects of ECT, which NIMH still calls the gold standard for treatment-resistant depression. For a deeper look, see our guides to TMS results and ketamine for depression.

What Happens After a Course of ECT?

Getting well and staying well are separate steps. A 2013 meta-analysis of 32 studies found that 37.7% of people relapsed within 6 months after successful ECT, even with continuation medication, and 51.1% relapsed by 12 months. Continuation ECT had a similar 6-month relapse rate of 37.2%. In randomized trials, antidepressants cut the 6-month relapse risk roughly in half compared with placebo.

So a course of ECT should come with a plan. NIMH notes that follow-up usually means antidepressant medication, maintenance ECT, or both, and that maintenance ECT can range from once a week to once every few months.

When to Get Help Right Away

ECT is for severe illness, and some situations can’t wait for a referral:

• If you’re having thoughts of suicide, call or text 988 to reach the Suicide and Crisis Lifeline.
• If you or someone else is in immediate danger, call 911.
• If someone has stopped eating or drinking, can’t move or respond, or is losing touch with reality, get emergency care now.

Retelling your history gets harder when depression is severe enough that ECT is on the table and you’re meeting yet another specialist.

ECT is a highly effective, carefully monitored treatment for severe depression, with memory effects that are real, usually temporary, and shaped by technique. The decision is about matching the treatment to how severe things are and how fast you need relief, and our guide to treatment-resistant depression walks through the steps that usually come first.

Ready to take control of your mental health? Start your anonymous intake with Siggy and get your plan reviewed by a licensed prescriber.

This article is for education only and isn’t a substitute for personal medical or mental health advice. It was reviewed for clinical accuracy and reflects sources available as of September 2026.